Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Brown & Brown, Inc. (“Brown & Brown" or the "Company") (NYSE:BRO) investors that the firm has initiated an...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Above Food Ingredients, Inc., (“Above Food" or the "Company") (NASDAQ:ABVE) investors that the firm has initiated an...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Medpace Holdings, Inc., (“Medpace" or the "Company") (NASDAQ:MEDP) investors that the firm has initiated an investigation...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises RPC, Inc. (“RPC" or the "Company") (NYSE:RES) investors that the firm has initiated an investigation into possible...
-
LOS ANGELES, April 01, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ichor Holdings, Ltd., (“Ichor" or the "Company") (NASDAQ:ICHR) investors that the firm has initiated an investigation...
-
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Vital Farms, Inc., (“Vital Farms” or the "Company") (NASDAQ: VITL) investors of a class action on behalf of investors...
-
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Aldeyra Therapeutics, Inc., (“Aldeyra” or the "Company") (NASDAQ: ALDX) investors of a class action on behalf of...
-
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Oracle Corporation, (“Oracle” or the "Company") (NYSE: ORCL) investors of a class action on behalf of investors that...
-
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Mereo BioPharma Group plc, (“Mereo” or the "Company") (NASDAQ: MREO) investors of a class action on behalf of investors...
-
LOS ANGELES, March 31, 2026 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Ultragenyx Pharmaceutical, Inc., (“Ultragenyx” or the "Company") (NASDAQ: RARE) investors of a class action on behalf of...